Source: International Congress 2018 – Biomarkers for evaluating COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Papathanassiou (Athens , Greece), A. Papaioannou (Athens, Greece), G. Hillas (Athens, Greece), E. Mizi (Athens , Greece), P. Bakakos (Athens, Greece), V. Apollonatou (Athens, Greece), G. Verykokou (Athens, Greece), N. Roussakis (Athens, Greece), Z. Tsilogianni (Athens, Greece), K. Kostikas (Athens, Greece), S. Papiris (Athens, Greece), S. Loukides (Athens, Greece). Glycated hemoglobin (HbA1c) and acute exacerbation in chronic obstructive pulmonary disease: a potent biomarker of severity and prognosis. Preliminary data.. 1079

Member's Comments

No comment yet.

Related content which might interest you: Haemoglobin as a biomarker for clinical outcomes in chronic obstructive pulmonary disease Source: ERJ Open Res, 7 (3) 00068-2021; 10.1183/23120541.00068-2021 Year: 2021 Relevance of hemoglobin A1c and acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Clinical value of C-reactive protein in severe acute exacerbations of COPD Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 Haemoglobin level and its clinical impact in a cohort of patients with COPD Source: Eur Respir J 2007; 29: 923-929 Year: 2007 Pro-adrenomedullin and pro-endothelin-1 for assessment and prognosis of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) Source: Eur Respir J 2007; 30: Suppl. 51, 39s Year: 2007 Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations. Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Relationships between C-reactive protein and disability in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005 Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001 Prognostic value of C-reactive protein in patients with severe to very severe chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006 Application of an outcome prediction model for hospitalized patients with exacerbation of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 55s Year: 2005 Study assoicção between severity stages of chronic obstructive pulmonary disease and fasting glucose in patients with this disease Source: Annual Congress 2013 –COPD and tobacco management Year: 2013 Carboxyhemoglobin (COHb) and bilirubin levels increase with acute exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 254s Year: 2002 Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Usefulness of admission red cell distribution Width as a predictor of early mortality in patients with severe exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Association between serum leptin, nutritional status and severity of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - COPD: from bench to bedside Year: 2008 Validity of serum surfactant protein D as a lung-specific biomarker in monitoring asthma, chronic obstructive pulmonary disease and chronic bronchitis in Lebanese patients: Preliminary results Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 C-reactive protein levels and clinically important predictive outcomes in stable COPD patients Source: Eur Respir J 2006; 27: 902-907 Year: 2006 Changes in antioxidant enzyme levels in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009 Potential biomarkers in patients with chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020